BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 333836)

  • 1. Liposomes as lymphokine activity indicators in the electrophoretic mobility test.
    Schütt W; Jenssen HL; Werner H; Köhler H
    Acta Biol Med Ger; 1977; 36(2):281-4. PubMed ID: 333836
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphokines which influence electrophoretic mobility of macrophages.
    Jenssen HL; Werner H; Köhler H
    Acta Biol Med Ger; 1976; 35(11):1499-503. PubMed ID: 1022133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of stimulated lymphocyte supernatants on the electrophoretic mobility distribution of peritoneal macrophages.
    Petty HR; Ware BR; Remold HG; Rocklin RE
    J Immunol; 1980 Jan; 124(1):381-7. PubMed ID: 6153099
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of supernatants from human mixed lymphocyte cultures on the electrophoretic mobility of guinea pig macrophages.
    Balakrishnan K; Hanjan SN; Talwar JP
    Transplantation; 1973 Dec; 16(6):678-80. PubMed ID: 4271113
    [No Abstract]   [Full Text] [Related]  

  • 6. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
    Preece AW; Light PA
    Clin Exp Immunol; 1974 Dec; 18(4):543-52. PubMed ID: 4143199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological control of lymphokine function.
    Yoshida T; Cohen S
    Fed Proc; 1982 Jun; 41(8):2480-3. PubMed ID: 7044831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Products of activated lymphocytes: leukocyte inhibitory factor (LIF) distinct from migration inhibitory factor (MIF).
    Rocklin RE
    J Immunol; 1974 Apr; 112(4):1461-6. PubMed ID: 4592603
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphokines, with special reference to skin reactive factor (SRF) (author's transl)].
    Aoki T
    Rinsho Byori; 1981 Dec; 29(12):1223-7. PubMed ID: 7040741
    [No Abstract]   [Full Text] [Related]  

  • 13. Guinea pig macrophage agglutination factor is antigenically distinct from migration inhibition factor and immunoglobulin.
    Godfrey HP; Geczy CL
    J Immunol; 1978 Oct; 121(4):1428-31. PubMed ID: 359706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
    Hammond ME; Selvaggio SS; Dvorak HF
    J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-lymphokine antibody. II. Specificity of biological activity.
    Kuratsuji T; Yoshida T; Cohen S
    J Immunol; 1976 Nov; 117(5 Pt.2):1985-91. PubMed ID: 792334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of the macrophage electrophoretic mobility test (M.E.M.).
    Shenton BR
    Boll Ist Sieroter Milan; 1978 Jan; 56(6):557-64. PubMed ID: 629849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity.
    Yoshida T; Cohen S
    J Immunol; 1974 Apr; 112(4):1540-7. PubMed ID: 4131167
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of the macrophage electrophoretic mobility test for the diagnosis of eye diseases.
    Jenssen R; Jenssen HL; Köhler H; Friemel H
    Mod Probl Ophthalmol; 1976; 16():259-64. PubMed ID: 943037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of lymphokines on macrophage accumulation and disappearance in the peritoneal cavity.
    D'Silva H; Yoshida T; Cohen S
    J Exp Pathol; 1983; 1(1):61-9. PubMed ID: 6400639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical characterization of radiolabeled lymphocyte activation products of guinea pig associated with macrophage migration inhibitory activity (MIF).
    Klinkert W; Sorg C
    Adv Exp Med Biol; 1979; 114():469-74. PubMed ID: 380298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.